Retrospective multicentre study on the effectiveness of first-line direct-acting antivirals against hepatitis C virus genotype-1.
Kaya M, Nakamura K, Sugiyama K, Kinae A, Yamaguchi H, Ukita H, Odagiri K, Ujiie C, Kato J, Kageyama F, Nagura M, Matsushita K, Sugiue K, Ishida H, Endo S, Suzuki T.
Kaya M, et al. Among authors: ishida h.
J Clin Pharm Ther. 2022 Jul;47(7):940-947. doi: 10.1111/jcpt.13624. Epub 2022 Feb 28.
J Clin Pharm Ther. 2022.
PMID: 35229326
Free PMC article.